Stryker to Acquire Artelon, Expanding Soft Tissue Fixation Solutions

Stryker (NYSE: SYK), a global medical technology leader, has signed an agreement to acquire Artelon, a company specializing in soft tissue fixation products for foot and ankle and sports medicine procedures. This acquisition aims to bolster Stryker’s capabilities in ligament and tendon reconstruction.

Artelon’s synthetic technology enhances biological and mechanical reconstruction, with over 60,000 implantations globally. The purchase will help Stryker offer more innovative biomaterial solutions, enhancing its competitiveness in the market.

Tim Lanier, president of Stryker’s Trauma & Extremities division, emphasized that Artelon’s product portfolio will strengthen Stryker’s offerings and support their mission to provide high-quality healthcare solutions.

The transaction is subject to customary closing conditions, with both companies operating independently until then.

Read the full release here.